Navigation Links
New Research Reveals Need for Doctors to Know About Medical Tattoos
Date:4/21/2009

HOUSTON, April 21 /PRNewswire-USNewswire/ -- More people are turning to a new trend to let others know about their medical condition - tattooing. A case report will be presented Friday, May 15, at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress shedding light on this new phenomenon, while urging discussion from the medical community.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

One of the most obvious benefits of medical tattooing is for identification purposes in an emergency situation, especially for patients with diabetes, when a patient may be incapacitated - particularly in the case of hypoglycemic coma. However, it also poses some health concerns - ones that the study's primary author, Saleh Aldasouqi, MD, FACE, feels the medical community may need to weigh in on.

"Like it or not, tattooing for purposes of medical alerts is a phenomenon that is now occurring," Dr. Aldasouqi said. "It's imperative that the medical community take note and that, perhaps, appropriate regulation of the practice be proposed, especially for patients with diabetes."

Once that happens, Dr. Aldasouqi hopes that patients and their doctors can sit down, analyze the risks and benefits, and make an informed decision together.

Also at the 2009 AACE 18th Annual Meeting & Clinical Congress, diabetes experts will analyze the NICE-SUGAR study's impact on inpatient glycemic control. Other topics of interest include a look at the wide ranging impact of vitamin D in the human body, and clinical recommendations for the treatment of prediabetes - America's largest healthcare epidemic.

A short, one page bio and photo of Dr. Aldasouqi are available here.

Media Registration

Media Registration for the AACE 18th Annual Meeting & Clinical Congress is available free of charge to members of the working media online here. Additional press releases concerning the meeting are available online here.

About AACE

AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.

About the AACE Annual Meeting

The 18th Annual Meeting & Clinical Congress will be held in Houston, Texas, on May 13-17 at the George R. Brown Convention Center, Hilton Americas Houston. The AACE Annual Meeting & Clinical Congress is structured to provide relevant clinical information for the practicing endocrinologist. The programs will focus on information that allows endocrinologists to achieve the best solutions for the diagnosis and management of endocrine diseases. Pertinent scientific, clinical practice and patient management will be disseminated via general sessions, workshops, meet-the-experts and satellite symposia.


'/>"/>
SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument
2. Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors
3. New Research Shows Healthy Choice Lives Up To Its Name
4. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
5. Mayo Clinic researchers formulate treatment combination lethal to pancreatic cancer cells
6. USC researchers develop new drug to target tumor cells and blood vessels
7. Medarex Announces Clinical Data for MDX-1401 in Hodgkins Lymphoma at Annual Meeting of the American Association for Cancer Research
8. Mersanas Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
9. LSUHSC research shows fish oil protects against diseases like Parkinsons
10. Autism Science Foundation Launches Operations; New Advocacy Group Will Focus on Non-vaccine-related Autism Research
11. Research Takes Aim at Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th ... Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised ... have been wounded in battle and their families. Venture Construction Group is a 2016 ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: